Other Information
−Removed: During the period from July 1, 2023, to September 30, 2023, our executive officers and directors adopted or terminated contracts, instructions or written plans for the purchase or sale of our securities as noted below:
+Added: During the period from January 1, 2024, to March 31, 2024, our executive officers and directors adopted or terminated contracts, instructions or written plans for the purchase or sale of our securities as noted below:
Name and Title Action Date Trading Arrangement Total Shares Authorized
1 unchanged sentence
Rule 10b5-1* Non-Rule 10b5-1**
−Removed: Adopt 8/22/2023 X 167,858 1/12/2024
−Removed: (Chief Executive Officer)
−Removed: Adopt 8/24/2023 X 61,749 8/07/2024
−Removed: (Chief Legal Officer)
+Added: 3/17/2024 X 88,495 6/13/2025
+Added: Chief Human Resources Officer
+Added: 3/15/2024 X 101,400 5/10/2025
+Added: Chief Business Development & Strategy Officer
+Added: 2/13/2024 X 45,000 2/15/2025
+Added: Chief Financial Officer
+Added: 2/13/2024 X 25,000 5/27/2025
______________
23 unchanged sentences
10.1+ Description:
+Added: Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement for grants on or after February 13, 2024 made under the Neurocrine Biosciences, Inc.
+Added: 2020 Equity Incentive Plan
+Added: 10.2+ Description:
+Added: Form of Stock Option Grant Notice and Option Agreement for grants made to Kevin Gorman on or after February 13, 2024 made under the Neurocrine Biosciences, Inc.
+Added: 2020 Equity Incentive Plan
+Added: 31.1 Description:
Certification of Chief Executive Officer pursuant to Rules 13a-14 and 15d-14 promulgated under the Securities Exchange Act of 1934
20 unchanged sentences
______________
+Added: + Management contract or compensatory arrangement.
* These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C.
3 unchanged sentences
NEUROCRINE BIOSCIENCES, INC.
−Removed: October 31, 2023
/s/ Matthew C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.